Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of pass/fail grading on medical students' well-being and academic outcomes.
Spring L, Robillard D, Gehlbach L, Simas TA. Spring L, et al. Med Educ. 2011 Sep;45(9):867-77. doi: 10.1111/j.1365-2923.2011.03989.x. Med Educ. 2011. PMID: 21848714 Review.
Research Biopsies: An Integrative Review of the Experiences of Patients With Cancer.
Abraham E, Post K, Spring L, Malvarosa G, Tripp E, Peppercorn JM, Bardia A, Habin K. Abraham E, et al. Among authors: spring l. Clin J Oncol Nurs. 2018 Jun 1;22(3):E71-E77. doi: 10.1188/18.CJON.E71-E77. Clin J Oncol Nurs. 2018. PMID: 29781452 Review.
SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?
Spring L, Bardia A. Spring L, et al. Lancet Oncol. 2017 May;18(5):564-565. doi: 10.1016/S1470-2045(17)30106-7. Epub 2017 Mar 15. Lancet Oncol. 2017. PMID: 28314690 No abstract available.
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.
Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes KS, Isakoff SJ, Ellisen LW, Smith BL, Specht M, Moy B, Bardia A. Spring L, et al. J Natl Compr Canc Netw. 2017 Oct;15(10):1216-1223. doi: 10.6004/jnccn.2017.0158. J Natl Compr Canc Netw. 2017. PMID: 28982747
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.
Condorelli R, Spring L, O'Shaughnessy J, Lacroix L, Bailleux C, Scott V, Dubois J, Nagy RJ, Lanman RB, Iafrate AJ, Andre F, Bardia A. Condorelli R, et al. Among authors: spring l. Ann Oncol. 2018 Mar 1;29(3):640-645. doi: 10.1093/annonc/mdx784. Ann Oncol. 2018. PMID: 29236940
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
Spring LM, Gupta A, Reynolds KL, Gadd MA, Ellisen LW, Isakoff SJ, Moy B, Bardia A. Spring LM, et al. JAMA Oncol. 2016 Nov 1;2(11):1477-1486. doi: 10.1001/jamaoncol.2016.1897. JAMA Oncol. 2016. PMID: 27367583 Free PMC article. Review.
Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer.
Zangardi ML, Spring LM, Blouin GC, Bardia A. Zangardi ML, et al. Among authors: spring lm. Expert Rev Clin Pharmacol. 2017 Nov;10(11):1169-1176. doi: 10.1080/17512433.2017.1376653. Epub 2017 Sep 18. Expert Rev Clin Pharmacol. 2017. PMID: 28875723 Review.
Cycling Toward Progress: Ribociclib, a CDK 4/6 Inhibitor for Breast Cancer.
Spring L, Bardia A. Spring L, et al. Clin Cancer Res. 2018 Jul 1;24(13):2981-2983. doi: 10.1158/1078-0432.CCR-18-0463. Epub 2018 Apr 23. Clin Cancer Res. 2018. PMID: 29685881
Stevens-Johnson syndrome-like eruption from palbociclib in a patient with metastatic breast cancer.
Karagounis T, Vallurupalli M, Nathan N, Nazarian R, Vedak P, Spring L, Chen ST. Karagounis T, et al. Among authors: spring l. JAAD Case Rep. 2018 Apr 30;4(5):452-454. doi: 10.1016/j.jdcr.2017.12.015. eCollection 2018 Jun. JAAD Case Rep. 2018. PMID: 29984280 Free PMC article. No abstract available.
Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.
Medford AJ, Dubash TD, Juric D, Spring L, Niemierko A, Vidula N, Peppercorn J, Isakoff S, Reeves BA, LiCausi JA, Wesley B, Malvarosa G, Yuen M, Wittner BS, Lawrence MS, Iafrate AJ, Ellisen L, Moy B, Toner M, Maheswaran S, Haber DA, Bardia A. Medford AJ, et al. Among authors: spring l. NPJ Precis Oncol. 2019 Jul 16;3:18. doi: 10.1038/s41698-019-0090-5. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 31341951 Free PMC article.